Notably, the MOB2-H157A mutant who fails to bind NDR1/2 exhibited similar effects as its wild type counterpart, suggesting that the effects of MOB2 in GBM cells might be NDR1/2-independent. The gene discussed is MOB2; the disease is glioblastoma.